Dosidal · Poland
Sandimmun
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:presentation:8945 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | rpl-pack-id: 8945 |
| Source authority | URPL |
| Read date | 2026-11-15T02:02:49Z |
| controlled status | availability_category: Lz definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf narcotic_or_psychotropic: False state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: L04AD01 authorisation_number: 01198 deleted: True form: Koncentrat do sporządzania roztworu do infuzji holder: Novartis Poland Sp. z o.o. medicine: Sandimmun pack_units: jednostkaPojemnosci: ml liczbaOpakowan: 10 pojemnosc: 5 rodzajOpakowania: amp. procedure: MRP routes: dożylna strength: 50 mg/ml substances: amount: 50 substance: Ciclosporinum unit: mg/ml state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| pack product code | state: unknown |
| prescription class | availability_category: Lz definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf prescription: True state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53XDhRn6fFgBcqLTF-v1bZbrYQO-gUxHRVw3dLWCZJbg6bEzuKZdAPzst4EH8PycdW9ZpvFVlD193hfZLWxtMpfwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/pl:presentation:8945 · Related records in other markets · Dosidal